Multiscale Reasoning For Human Physiology RFI

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DEF ADVANCED RESEARCH PROJECTS AGCY

Contract Value

Not provided

Codes & Classification
Solicitation Number

DARPA-SN-26-100

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Classification Code

AC12

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents2
The Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), has issued a Special Notice (DARPA-SN-26-100) as a Request for Information (RFI) titled "Multiscale Reasoning For Human Physiology." This RFI seeks to gather input from a broad spectrum of stakeholders—including industry, academia, government laboratories, healthcare organizations, and non-traditional performers—regarding innovative technologies, datasets, computational frameworks, artificial intelligence systems, and foundational models that can facilitate multiscale reasoning across human physiology. The primary objective of this procurement activity is to identify and assess emerging capabilities that enable the integration and analysis of physiological data across multiple biological scales. The intended outcome is to inform future DARPA initiatives aimed at advancing the understanding and modeling of human physiology through sophisticated computational and AI-driven approaches. Respondents are encouraged to provide insights into current and anticipated technological advancements, relevant datasets, and methodologies that could support comprehensive, multiscale reasoning in this domain. Key requirements for this RFI include the submission of information related to: - Emerging technologies and computational frameworks capable of multiscale physiological reasoning - Artificial intelligence systems and foundation models applicable to human physiology - Relevant datasets that could support research and development in this area The RFI is classified under NAICS code 541714, which pertains to Research and Development in Biotechnology (except Nanobiotechnology), and is further identified by Product Service Code AC12. The contracting entity is the Defense Advanced Research Projects Agency (DARPA), a federal office within the Department of Defense, specifically managed by the Biological Technologies Office. Interested parties should note that this is a Special Notice and not a solicitation for proposals or quotations. The RFI is intended solely for information gathering purposes to inform potential future procurement activities. There are no set-aside requirements or specific procurement types indicated at this stage, and no contractual obligations will result from responses to this notice. The primary point of contact for this RFI is Dr. Roozbeh Jafari, Program Manager at DARPA/BTO, who can be reached via email at [email protected]. The notice remains active, with a response deadline set for August 20, 2026. Additional details, including attachments, can be accessed through the official SAM.gov opportunity page at https://sam.gov/opp/75a6c5433f00498e8b8e6a6fe6892606/view. Contractors with expertise in biotechnology research and development, particularly those with capabilities in computational modeling, artificial intelligence, and data integration across biological scales, are encouraged to review the RFI and consider submitting relevant information. This opportunity is particularly well-suited for organizations at the forefront of technological innovation in human physiology and multiscale data analysis.